Abstract:Idiopathic pulmonary fibrosis is a chronic, progressive, and scarring lung disease with an unknown etiology. Homeodomain Interacting Protein Kinase 2 ( HIPK2) is a co-transcriptional regulator involved in kidney fibrosis. We hypothesize that a decrease in HIPK2 expression attenuates the activation and proliferation of lung fibroblasts through inhibition of TGF-β1 and Wnt 3a pathways. HIPK2 knockdown using a lentiviral shRNA in human pulmonary fibroblasts (HPFs) reduced TGF-β1- and WNT3a-induced expression of fibrotic markers including α-smooth actin, fibronectin, and collagen 1A1 and 3A1 as determined by Western blots and real-time PCR. Immunostaining of α-smooth actin showed that HIPK2 knockdown inhibited fiber formation in HPFs. Furthermore, HIPK2 knockdown suppressed fibroblast proliferation. HIPK2 knockdown in HPFs also resulted in a reduction in TGF-β1-induced SMAD 2/3 phosphorylation and WNT3a-induced activated β-Catenin expression, suggesting the involvement of HIPK2 regulation on above pathways. To investigate the effects of HIPK2 knockdown on lung fibrosis in mice, HIPK2 was knocked down (KD) in the lungs of mice using an adenovirus expressing 4 shRNAs targeting HIPK2 and lung fibrosis was induced by an intratracheal instillation of bleomycin (1U/kg body weight) for 14 days. HIPK2 KD mice lost less body weight compared to the control mice. Analysis of bronchoalveolar lavage (BAL) indicated a significant reduction in total infiltrated immune cells in Hipk2 KD mice. Lung fibrosis was reduced in Hipk2 KD mice as demonstrated by fibrotic score, Sirius red staining, fibronectin mRNA level, and collagen content as measured by hydroxyproline assay. Lung functions including elastance, compliance, resistance, and inspiratory capacity, as determined by Flexivent, were improved in Hipk2 KD mice. Real-time PCR and ELISA revealed a significantly reduced mRNA expression of Tgf-β1 in the lung tissues and a decreased TGF-β1 level in BAL fluids of Hipk2 KD mice. Immunofluorescence indicated reduced SMAD-3 and activated β-Catenin levels in the fibrotic regions of Hipk2 KD mice. These findings clearly suggest that reduced HIPK2 expression in the lung attenuates lung fibrosis through the suppression of TGF-β1 and WNT3a signaling pathways. R01 HL157450, R01HL135152 and P20GM103648 This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Loss of Protein Kinase D2 Activity Protects Against Bleomycin-Induced Dermal Fibrosis in Mice

Protein Kinase C Δ (pkcδ) Attenuates Bleomycin Induced Pulmonary Fibrosis Via Inhibiting NF-κB Signaling Pathway.

PKM2 Promotes Pulmonary Fibrosis by Stabilizing TGF-β1 Receptor I and Enhancing TGF-β1 Signaling.

The Wnt antagonist Dickkopf1(DKK1) promotes pulmonary fibrosis via M2-like macrophage polarization

MKP-1 Deficiency Exacerbates Skin Fibrosis in a Mouse Model of Scleroderma

Discoidin domain receptor 2 signaling through PIK3C2α in fibroblasts promotes lung fibrosis

AKT2 Regulates Pulmonary Inflammation and Fibrosis Via Modulating Macrophage Activation

Ketogenic diet induces autophagy to alleviate bleomycin-induced pulmonary fibrosis in murine models

Deletion of Protein Kinase D3 Promotes Liver Fibrosis in Mice

Pirfenidone and nintedanib attenuate pulmonary fibrosis in mice by inhibiting the expression of JAK2

Knockdown of phosphoinositide-dependent kinase 1 (PDK1) inhibits fibrosis and inflammation in lipopolysaccharide-induced acute lung injury rat model by attenuating NF-κB/p65 pathway activation

17,20S(OH)2pD Can Prevent the Development of Skin Fibrosis in the Bleomycin-Induced Scleroderma Mouse Model

A reduction in Homeodomain Interacting Protein Kinase-2 in lung fibroblasts ameliorates lung fibrosis

PKM2/Hif-1α Signal Suppression Involved in Therapeutics of Pulmonary Fibrosis with Microcystin-Rr but Not with Pirfenidone

Extracellular PKM2 Facilitates Organ-Tissue Fibrosis Progression.

Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in mice

Phycocyanin attenuates pulmonary fibrosis via the TLR2-MyD88-NF-κB signaling pathway

Epithelium-specific Deletion of TGF-β Receptor Type II Protects Mice from Bleomycin-Induced Pulmonary Fibrosis.

Targeting of discoidin domain receptor 2 (DDR2) prevents myofibroblast activation and neovessel formation during pulmonary fibrosis

Inhibition of Wnt/β-catenin Signaling Suppresses Bleomycin-Induced Pulmonary Fibrosis by Attenuating the Expression of TGF-β1 and FGF-2.

Lactate accumulation induced by Akt2-PDK1 signaling promotes pulmonary fibrosis